Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Molecular Markers in Adrenal Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~  1. An individual with a primary localized adrenal neoplasm greater than 2 cm in size~ 2. Age greater than or equal to 18 years~ 3. Adults must be able to understand and sign the informed consent document~ 4. Patients must have an Eastern Cooperative Oncology Group (ECOG) performance score of 0-2.~ 5. Patients must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to biopsy or surgery Note: patients with suspected but unconfirmed adrenal neoplasm may be enrolled.~EXCLUSION CRITERIA:~1. Biochemically proven Pheochromocytoma~2. Women who are pregnant because of the possible side effects of radiation from computed tomography (CT)-guided biopsies to the unborn child.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Adrenal Gland Neoplasm (Type: None): To collect adrenal tumor tissue biopsy samples in order to study and evaluate new methods that may help identify cancerous or precancerous cells. Participants who have a large tumor or one that secretes hormones will have standard surgery to remove the tumor.

Based on this trial design, predict the completion outcome and termination type (if applicable).